In vitro-Transcribed mRNA Therapeutics: Out of the Shadows and Into the Spotlight
Mol Ther
.
2019 Apr 10;27(4):691-692.
doi: 10.1016/j.ymthe.2019.03.009.
Epub 2019 Mar 21.
Author
Katalin Karikó
1
Affiliation
1
BioNTech RNA Pharmaceuticals, Mainz, Germany. Electronic address: katalin.kariko@biontech.de.
PMID:
30905578
PMCID:
PMC6453554
DOI:
10.1016/j.ymthe.2019.03.009
No abstract available
Publication types
Editorial
MeSH terms
Cancer Vaccines
Drug Delivery Systems
Genetic Therapy / adverse effects
Humans
In Vitro Techniques
RNA, Messenger / therapeutic use*
Transcription, Genetic*
Substances
Cancer Vaccines
RNA, Messenger